Vaccinia Virus Converts Microglia into Potent Oncolytic Agent for Glioblastoma and Neuroblastoma

This microglia-based delivery strategy enables potent oncolytic activity against brain tumor cells and warrants further exploration in in vivo and combinational therapies.

Authors

Institutions

Publication Details

Journal
Cells
Published
2025-12-08
DOI
https://doi.org/10.3390/cells14241943
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vaccinia Virus Converts Microglia into Potent Oncolytic Agent for Glioblastoma and Neuroblastoma

Parisa Ghanbari, Eman M. Othman, Elena Ekrami, Aladar A. Szalay
Cells
Virus-based gene therapy research
article

Vaccinia Virus Converts Microglia into Potent Oncolytic Agent for Glioblastoma and Neuroblastoma

Parisa Ghanbari, Eman M. Othman, Elena Ekrami, Aladar A. Szalay
article en

Abstract

This microglia-based delivery strategy enables potent oncolytic activity against brain tumor cells and warrants further exploration in in vivo and combinational therapies.

CellsVol. 14(24)
University of Würzburg (DE), University of California San Diego (US), Stanford Medicine (US)
Openalex Percentile: Top 59%
Virus-based gene therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.